Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IL-10 anticorps

L’anticorps Rat Monoclonal anti-IL-10 a été validé pour ELISA, Neut et ICS. Il convient pour détecter IL-10 dans des échantillons de Humain et Virus. Il y a 4+ publications disponibles.
N° du produit ABIN1177280

Aperçu rapide pour IL-10 anticorps (ABIN1177280)

Antigène

Voir toutes IL-10 (IL10) Anticorps
IL-10 (IL10) (Interleukin 10 (IL10))

Reactivité

  • 159
  • 97
  • 55
  • 21
  • 17
  • 12
  • 10
  • 8
  • 8
  • 7
  • 6
  • 5
  • 5
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Humain, Virus

Hôte

  • 135
  • 80
  • 76
  • 4
  • 2
  • 2
  • 2
Rat

Clonalité

  • 170
  • 128
  • 1
Monoclonal

Conjugué

  • 183
  • 37
  • 12
  • 12
  • 10
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp IL-10 est non-conjugé

Application

  • 185
  • 128
  • 108
  • 66
  • 64
  • 52
  • 29
  • 17
  • 16
  • 16
  • 15
  • 14
  • 14
  • 12
  • 11
  • 9
  • 8
  • 8
  • 7
  • 7
  • 4
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Neutralization (Neut), Intracellular Staining (ICS)

Clone

JES3-9D7
  • Marque

    BD Pharmingen™

    Attributs du produit

    Neutralization Activity: This antibody has been reported to be useful for the neutralization of recombinant human IL-10. Neutralization activity may be measured with a proliferation assay using 3 ng/mL recombinant human IL-10 (Cat.No. 554611), co-stimulated with 0.1 ng/mL recombinant mouse IL-4 (Cat.No. 550067), to stimulate MC/9 or D36 cells as indicator cells (i.e preincubation of the antibody with recombinant human IL-10 for 60 min)
    50% Neutralization (ND50) at 0.2 - 4.0 ng/mL
    >95% Neutralization at 3 - 30 ng/mL

    Purification

    The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.

    Stérilité

    0.2 μm filtered

    niveau d'endotoxine

    Endotoxin level is ≤ 0.01 EU/μg (≤ 0.001 ng/μg) of protein as determined by the LAL assay.

    Immunogène

    Recombinant Human IL-10

    Isotype

    IgG1
  • Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1.0 mg/mL

    Buffer

    No azide/low endotoxin: Aqueous buffered solution containing no preservative, 0.2μm sterile filtered.

    Agent conservateur

    Azide free

    Stock

    4 °C

    Stockage commentaire

    Store undiluted at 4°C. This preparation contains no preservatives, thus it should be handled under aseptic conditions.
  • Abrams: "Immunoenzymetric assay of mouse and human cytokines using NIP-labeled anti-cytokine antibodies." dans: Current protocols in immunology / edited by John E. Coligan ... [et al.], Vol. Chapter 6, pp. Unit 6.20, (2008) (PubMed).

    Burdin, Péronne, Banchereau, Rousset: "Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10." dans: The Journal of experimental medicine, Vol. 177, Issue 2, pp. 295-304, (1993) (PubMed).

    Abrams, Roncarolo, Yssel, Andersson, Gleich, Silver: "Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples." dans: Immunological reviews, Vol. 127, Issue 9-10, pp. 5-24, (1992) (PubMed).

    Gotlieb, Abrams, Watson, Velu, Berek, Martínez-Maza: "Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers." dans: Cytokine, Vol. 4, Issue 5, pp. 385-90, (1992) (PubMed).

  • Antigène

    IL-10 (IL10) (Interleukin 10 (IL10))

    Autre désignation

    IL-10

    Sujet

    The JES3-9D7 antibody reacts with human IL-10 and viral IL-10. The immunogen used to generate the JES3-9D7 hybridoma was recombinant human IL-10 expressed in COS cells.

    Pathways

    Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Maintenance of Protein Location, Cancer Immune Checkpoints
Vous êtes ici:
Chat with us!